These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
415 related items for PubMed ID: 1461545
1. [Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)]. Diacinti D, Salabè GB, Olivieri A, D'Erasmo E, Tomei E, Lotz-Salabè H, De Martinis C. Minerva Med; 1992 Nov; 83(11):745-51. PubMed ID: 1461545 [Abstract] [Full Text] [Related]
4. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study. Appetecchia M. Horm Res; 2005 Nov; 64(6):293-8. PubMed ID: 16269872 [Abstract] [Full Text] [Related]
6. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial. Bennedbaek FN, Nielsen LK, Hegedüs L. J Clin Endocrinol Metab; 1998 Mar; 83(3):830-5. PubMed ID: 9506736 [Abstract] [Full Text] [Related]
7. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. Papini E, Petrucci L, Guglielmi R, Panunzi C, Rinaldi R, Bacci V, Crescenzi A, Nardi F, Fabbrini R, Pacella CM. J Clin Endocrinol Metab; 1998 Mar; 83(3):780-3. PubMed ID: 9506726 [Abstract] [Full Text] [Related]
8. Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal women. Costante G, Crocetti U, Schifino E, Ludovico O, Capula C, Nicotera M, Arturi F, Filetti S. J Endocrinol Invest; 2004 Jan; 27(1):31-6. PubMed ID: 15053240 [Abstract] [Full Text] [Related]
9. Long-term follow-up of thyroid nodule growth. Quadbeck B, Pruellage J, Roggenbuck U, Hirche H, Janssen OE, Mann K, Hoermann R. Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):348-54. PubMed ID: 12397534 [Abstract] [Full Text] [Related]
13. Thyroid morphology and function after surgical treatment of thyroid diseases. Mann B, Schmale P, Stremmel W. Exp Clin Endocrinol Diabetes; 1996 Oct; 104(3):271-7. PubMed ID: 8817246 [Abstract] [Full Text] [Related]
14. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease. De Rosa G, Testa A, Giacomini D, Carrozza C, Maussier ML, Valenza V, D'Errico GF. Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104 [Abstract] [Full Text] [Related]
15. Levothyroxine suppressive therapy in the medical management of nontoxic benign multinodular goiter. Celani MF. Exp Clin Endocrinol; 1993 Jun; 101(5):326-32. PubMed ID: 8299711 [Abstract] [Full Text] [Related]
16. Efficacy of thyroxine-suppressive therapy and its relation to serum thyroglobulin levels in solitary nontoxic thyroid nodules. Kuo SW, Hu CA, Pei D, Ni KB, Shian LR. J Formos Med Assoc; 1993 Jan; 92(1):55-60. PubMed ID: 8099828 [Abstract] [Full Text] [Related]